includes controlled-release drug formulations designed to regulate metabolic and neurological pathways.

The organization advances drug candidates through clinical trials and regulatory processes while also supporting approved therapies in the market. It integrates scientific research, medical affairs, and patient-focused initiatives to guide treatment adoption and ongoing study. Soleno Therapeutics also collaborates with healthcare stakeholders to improve understanding of rare disease management and treatment outcomes.